Deal Type

Fresenius, a Germany-based global healthcare company, is receiving a new €400m (US$470m) loan from the European Investment Bank (EIB) to strengthen Fresenius’ European R&D...

NRG Therapeutics, a neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has closed an oversubscribed £50m (US$67m) Series B financing that will...

One of the world’s largest infrastructure asset managers, Australia-based Macquarie Asset Management, via Macquarie European Infrastructure Fund 7, has agreed to acquire a 40%...

France-based SGD Pharma, a PAI Partners portfolio company providing pharmaceutical glass packaging, has acquired Italy-based Alphial, a producer of tubular vials and ampoules, from...

In July, UK-based CRO Evestia Clinical acquired Atlantic Research Group (ARG), a US-based CRO, to create a global specialist CRO group. The merger expands...

Denmark-based Abacus Medicine, one of Europe’s leading parallel traders of medicine, is to acquire the Retail and Hospital (R&H) division of global specialty pharma...

France-based SeqOne, a European provider of AI-powered software for next-generation sequencing (NGS) data analysis, is paying an undisclosed amount to acquire Congenica, the UK company...

Italy-based Fidia Farmaceutici, a multinational developer company specialising in the development, manufacturing and marketing of products across joint, skin, eye, specialty and health and wellness care,...

Quasar Medical, a Singapore-headquartered manufacturer of interventional and minimally invasive medical devices, has completed its acquisition of Nasdaq-listed Nordson Corporation’s design & development contract...

Avista Healthcare Partners (Avista), a US-based private equity firm focused exclusively on healthcare, has agreed to invest in PK Benelux, a key player in...